TY  - GEN
AU  - Buchanan,Robert W
AU  - Davis,Miriam
AU  - Goff,Donald
AU  - Green,Michael F
AU  - Keefe,Richard S E
AU  - Leon,Andrew C
AU  - Nuechterlein,Keith H
AU  - Laughren,Thomas
AU  - Levin,Robert
AU  - Stover,Ellen
AU  - Fenton,Wayne
AU  - Marder,Steve R
TI  - A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
SN  - 0586-7614
PY  - 2005///0630
KW  - Antipsychotic Agents
KW  - Brief Psychiatric Rating Scale
KW  - Clinical Trials as Topic
KW  - standards
KW  - Cognition Disorders
KW  - diagnosis
KW  - Combined Modality Therapy
KW  - Guidelines as Topic
KW  - Health Promotion
KW  - Humans
KW  - Mental Health Services
KW  - National Institute of Mental Health (U.S.)
KW  - Polypharmacy
KW  - Psychotherapy
KW  - Schizophrenia
KW  - complications
KW  - Severity of Illness Index
KW  - Treatment Outcome
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Congress; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1093/schbul/sbi020
ER  -